YINasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends December 31
111, Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$3.13+0.00 (+0.16%)
Close on Oct 19, 2026
111, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B2C segment | – | – | – | – | CN¥491.86M | CN¥666.22M | CN¥636.43M | CN¥709.59M | CN¥862.33M | CN¥870.36M | – | – |
| B2B segment | – | – | – | – | CN¥11.84B | CN¥7.49B | CN¥3.29B | CN¥1.06B | CN¥86.89M | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenues | CN¥12.47B | CN¥14.29B | CN¥14.84B | CN¥13.40B | CN¥12.33B | CN¥8.16B | CN¥3.93B | CN¥1.77B | CN¥949.22M | CN¥870.36M | 99.3% | -12.8% |
| B2B segment | CN¥12.25B | CN¥14.03B | CN¥14.48B | CN¥13.00B | CN¥11.84B | CN¥7.49B | CN¥3.29B | CN¥1.06B | CN¥86.89M | – | 97.5% | -12.7% |
| Drugs | CN¥11.65B | CN¥13.40B | CN¥13.88B | CN¥12.57B | CN¥11.68B | CN¥7.40B | CN¥3.60B | CN¥1.49B | CN¥649.34M | CN¥541.32M | 92.8% | -13.0% |
| Nutritional supplements | CN¥434.69M | CN¥550.46M | CN¥631.12M | CN¥554.79M | CN¥442.50M | CN¥559.24M | CN¥245.64M | CN¥190.43M | CN¥123.21M | CN¥110.30M | 3.5% | -21.0% |
| Other products | CN¥233.69M | CN¥201.83M | CN¥170.23M | CN¥111.10M | CN¥83.18M | CN¥49.95M | CN¥20.35M | CN¥16.03M | CN¥19.97M | CN¥34.38M | 1.9% | +15.8% |
| B2C segment | CN¥223.22M | CN¥261.20M | CN¥357.98M | CN¥408.31M | CN¥491.86M | CN¥666.22M | CN¥636.43M | CN¥709.59M | CN¥862.33M | CN¥870.36M | 1.8% | -14.5% |
| Medical supplies and devices | CN¥152.35M | CN¥144.28M | CN¥157.50M | CN¥164.92M | CN¥124.92M | CN¥149.05M | CN¥50.18M | CN¥26.56M | CN¥49.41M | CN¥68.82M | 1.2% | +5.6% |
| Service | CN¥85.38M | CN¥106.51M | CN¥106.22M | CN¥113.26M | CN¥94.20M | CN¥46.49M | CN¥22.36M | CN¥14.83M | CN¥10.27M | CN¥3.48M | 0.7% | -19.8% |
| MP Service | CN¥56.75M | CN¥65.54M | CN¥70.27M | CN¥68.48M | CN¥52.31M | CN¥30.53M | CN¥17.24M | CN¥12.49M | CN¥8.77M | CN¥2.47M | 0.5% | -13.4% |
| Other Services | CN¥28.63M | CN¥40.97M | CN¥35.95M | CN¥44.79M | CN¥41.89M | CN¥15.95M | CN¥5.12M | CN¥2.34M | CN¥1.50M | CN¥1.00M | 0.2% | -30.1% |
| Contact lenses. | – | – | – | – | CN¥38.00K | CN¥3.42M | CN¥18.11M | CN¥47.30M | CN¥107.28M | CN¥115.55M | – | – |
By region
From the segment and revenue-disaggregation notes of 111's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.